Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA1817769
Max Phase: Preclinical
Molecular Formula: C39H65N13O11S2
Molecular Weight: 956.16
Molecule Type: Protein
Associated Items:
ID: ALA1817769
Max Phase: Preclinical
Molecular Formula: C39H65N13O11S2
Molecular Weight: 956.16
Molecule Type: Protein
Associated Items:
Canonical SMILES: CC[C@H](C)[C@@H]1NC(=O)[C@H](CC2CCCC2)NC(=O)[C@@H](N)CSSC[C@@H](C(=O)N2CCC[C@H]2C(=O)N[C@@H](CCN)C(=O)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CC(N)=O)NC1=O
Standard InChI: InChI=1S/C39H65N13O11S2/c1-3-19(2)31-38(62)49-25(15-29(43)54)34(58)48-24(14-28(42)53)35(59)50-26(18-65-64-17-21(41)32(56)47-23(36(60)51-31)13-20-7-4-5-8-20)39(63)52-12-6-9-27(52)37(61)46-22(10-11-40)33(57)45-16-30(44)55/h19-27,31H,3-18,40-41H2,1-2H3,(H2,42,53)(H2,43,54)(H2,44,55)(H,45,57)(H,46,61)(H,47,56)(H,48,58)(H,49,62)(H,50,59)(H,51,60)/t19-,21-,22-,23-,24-,25-,26-,27-,31-/m0/s1
Standard InChI Key: CKMDIWZLFAHZIL-DSMBUKBGSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Protein | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 956.16 | Molecular Weight (Monoisotopic): 955.4368 | AlogP: -5.06 | #Rotatable Bonds: 16 |
Polar Surface Area: 405.32 | Molecular Species: BASE | HBA: 15 | HBD: 12 |
#RO5 Violations: 3 | HBA (Lipinski): 24 | HBD (Lipinski): 17 | #RO5 Violations (Lipinski): 3 |
CX Acidic pKa: 11.32 | CX Basic pKa: 9.54 | CX LogP: -7.17 | CX LogD: -9.71 |
Aromatic Rings: 0 | Heavy Atoms: 65 | QED Weighted: 0.06 | Np Likeness Score: 0.34 |
1. Wisniewski K, Galyean R, Tariga H, Alagarsamy S, Croston G, Heitzmann J, Kohan A, Wisniewska H, Laporte R, Rivière PJ, Schteingart CD.. (2011) New, potent, selective, and short-acting peptidic V1a receptor agonists., 54 (13): [PMID:21688787] [10.1021/jm200278m] |
Source(1):